Newsroom

HMI’ bacteriophage research is in the Top 100 Scientific Reports Microbiology papers in 2017

HMI’ bacteriophage research is in the Top 100 Scientific Reports Microbiology papers in 2017

NEW YORK, NY / ACCESSWIRE / April 18, 2018 /  Bacteriophages as potential new mammalian pathogens’ has been selected as one of the top 100 read microbiology papers for Scientific Reports in 2017*, New York based HumanMicrobiology Institute (HMI) announced today. 

Interview: Is Alzheimer’s caused by bacteriophages?

Interview: Is Alzheimer’s caused by bacteriophages? SPECIAL

BY TIM SANDLE      NOV 9, 2017 IN SCIENCE
New York – Scientists have reported on a breakthrough that may change conventional understanding of causes for many diseases like Alzheimer’s. This relates to viruses called bacteriophages. To find out more we spoke with Dr. George Tetz.Dr. George Tetz has led a research team that has recently presented important datathat could change the conventional medical understanding of causes for many diseases, like Alzheimer’s disease, together with other neurodegenerative diseases. This is that neurodegenerative diseases can be caused by bacteriophages. These are viruses that infect and replicate within bacteria. In the context of the new research, this is with the gut microbiota of humans and other mammals.  Dr. Tetz is involved with the Human Microbiology Institute, which is based in New York. To find out more, Digital Journal spoke with the researcher about the last findings and their implication

.

NY Scientists First to Link Neurodegenerative Diseases and Bacterial Viruses

NY Scientists First to Link Neurodegenerative Diseases and Bacterial Viruses

NEW YORK, NY / ACCESSWIRE / October 17, 2017 / Alzheimer’s and many other neurodegenerative diseases can be caused by bacteriophages – viruses that infect and replicate within gut microbiota of humans and other mammals, New York based HumanMicrobiology Institute (HMI) announced today. The groundbreaking research findings were reported during an Oral Presentation at the American Society for Microbiology’s gathering at the University of Connecticut. The research project was done in collaboration with NYU scientists and results were recently published in highly reputable Nature’s Scientific Reports.

Human Microbiology Institute: Bacteriophages May Cause Neurodegenerative Diseases

Viruses Called Bacteriophages Affect Bacteria in Mammal Gut Environment and May Cause Human Diseases, a Study from Human Microbiology Institute Reveals

NEW YORK, NY, July 12, 2017 — Viruses called bacteriophages affect bacteria that populate mammal gut environment and may cause human diseases, according to the Human Microbiology Institute (HMI). The revolutionary findings were revealed today during an oral presentation at the largest European microbiologist gathering, FEMS-2017 in Spain.

Research Presented in an Oral Session at ASM Microbe 2017: Bacteriophages are Potential New Human Pathogens

Bacteriophages are Potential New Human Pathogens

Human Microbiology Institute Research the First to Demonstrate that Bacteriophages Can Alter Gut Microbiome Causing Increased Gut Permeability, Which is Associated with Human Diseases

 Research Presented in an Oral Session at American Society for Microbiology (ASM) Microbe 2017

 

NEW YORK, NY, June 5, 2017 — Human Microbiology Institute (HMI), a not-for-profit scientific research organization founded by Drs. Victor and George Tetz, today presented data that demonstrate for the first time how viruses pathogenic to bacteria, called bacteriophages, can play a role in the development of mammalian disease. The study, conducted by Drs. V. and G. Tetz, was presented by Dr. G. Tetz in an oral session at American Society for Microbiology (ASM) Microbe 2017, June 1–5, 2017, in New Orleans.

Research Presented in an Oral Session at ASM Microbe 2017: Introducing the Sporobiota

Introducing the Sporobiota: Spore-Forming Bacteria that Share Unique Characteristics Including Similar Human Health Challenges

Research Presented in an Oral Session at American Society for Microbiology (ASM) Microbe 2017

NEW YORK, NY, June 5, 2017 — Human Microbiology Institute (HMI), a not-for-profit scientific research organization founded by Drs. Victor and George Tetz, today proposed that the Sporobiota, unrelated spore-forming bacteria that share unique characteristics because of their spore-forming capabilities, pose significant challenges to human health. The study, conducted by Drs. V. and G. Tetz, supporting the Sporobiota as an important and newly recognized potential human pathogenic class were presented by Dr. G. Tetz in an oral session at American Society for Microbiology (ASM) Microbe 2017, June 1–5, 2017, in New Orleans.

Introducing the Sporobiome: Human Microbiology Institute to Present at ASM Microbe 2017

 

NEW YORK (April 17, 2017) – Human Microbiology Institute, a not-for-profit scientific research organization, today announced that George Tetz and Victor Tetz will present data for the research study  “INTRODUCING THE SPOROBIOME: AN UNEXPLORED NEXUS OF RESISTOME AND NOVEL HUMAN PATHOGENS” as an oral presentation at the ASM Microbe 2017 Conference (June 1–5, 2017, New Orleans, LA).

New Research Indicates Alzheimer’s and Other Neurodegenerative Diseases Are Contagious

NEW YORK, Sept. 23, 2016 – Alzheimer’s, cancer and other incurable diseases such as Parkinson’s and dementia can be contagious, according to researchers at the Human Microbiology Institute, who have published research linking the diseases to newly discovered bacterial viruses.

New York Research Institute Publishes Case Report on Promising New Alzheimer’s Treatment

NEW YORK, June 7, 2016 /PRNewswire/ — Researchers at the Human Microbiology Institute (HMI) have uncovered a potential new Alzheimer’s treatment that significantly reversed the late-stage effects of the debilitating neurodegenerative disease.

Experimental treatment for dementia in end-stage Alzheimer’s disease: a case report

NEW YORK (May 27, 2016) – Human Microbiology Institute, delighted to present that its scientific core has been in the background of groundbreaking study for the compassionate use study of dementia in end-stage Alzheimer’s disease.

12